FibroBiologics announces new U.S. patent for degenerative disc disease
FibroBiologics said it has been issued a new U.S. patent covering treatment of degenerative disc disease using fibroblast conditioned media.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.